Payel Chatterjee
Overview
Explore the profile of Payel Chatterjee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1079
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Welch S, Spengler J, Westover J, Bailey K, Davies K, Aida-Ficken V, et al.
Sci Transl Med
. 2024 Nov;
16(774):eado7034.
PMID: 39565871
Development of broad-spectrum antiviral therapies is critical for outbreak and pandemic preparedness against emerging and reemerging viruses. Viruses inducing hemorrhagic fevers cause high morbidity and mortality in humans and are...
2.
Lo M, Jain S, Davies K, Sorvillo T, Welch S, Coleman-McCray J, et al.
Antiviral Res
. 2024 Sep;
231:106013.
PMID: 39326503
Nipah virus (NiV) causes near-annual outbreaks of fatal encephalitis and respiratory disease in South Asia with a high mortality rate (∼70%). Since there are no approved therapeutics for NiV disease...
3.
Chatterjee P, Martin K
Circulation
. 2024 Jun;
149(24):1899-1902.
PMID: 38857330
No abstract available.
4.
Aida-Ficken V, Kelly J, Chatterjee P, Jenks M, McMullan L, Albarino C, et al.
Antiviral Res
. 2024 Jun;
228:105923.
PMID: 38844175
There are no approved vaccines or therapeutics for Lassa virus (LASV) infections. To identify compounds with anti-LASV activity, we conducted a cell-based screening campaign at biosafety level 4 and tested...
5.
Lester S, Stumpf M, Freeman B, Mills L, Schiffer J, Semenova V, et al.
Access Microbiol
. 2024 Mar;
6(2).
PMID: 38482357
Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) is a novel human coronavirus that was identified in 2019. SARS-CoV-2 infection results in an acute, severe respiratory disease called coronavirus disease...
6.
Al-Aloosi M, Prechtl A, Chatterjee P, Bernard B, Kemp C, Rosati R, et al.
Front Oncol
. 2024 Jan;
13:1267650.
PMID: 38239650
Patients presenting with stage 4 ovarian carcinoma, including low-grade serous disease, have a poor prognosis. Although platinum-based therapies can offer some response, these therapies are associated with many side effects,...
7.
Gil da Costa R, Levesque C, Bianchi-Frias D, Chatterjee P, Lam H, Santos C, et al.
Mol Oncol
. 2023 Aug;
17(12):2709-2727.
PMID: 37533407
Most patients with muscle-invasive bladder cancer (MIBC) are not cured with platinum chemotherapy. Up-regulation of nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) is a major mechanism underlying...
8.
Gray H, Chatterjee P, Rosati R, Appleyard L, Durenberger G, Diaz R, et al.
NPJ Precis Oncol
. 2023 May;
7(1):45.
PMID: 37202426
Low-grade serous ovarian cancer (LGSOC) typically responds poorly to standard platinum-based chemotherapy and new therapeutic approaches are needed. We describe a remarkable response to targeted therapy in a patient with...
9.
Shrivastava-Ranjan P, Jain S, Chatterjee P, Montgomery J, Flint M, Albarino C, et al.
Antiviral Res
. 2023 May;
214:105619.
PMID: 37142192
Seoul virus (SEOV) is an emerging global health threat that can cause hemorrhagic fever with renal syndrome (HFRS), which results in case fatality rates of ∼2%. There are no approved...
10.
King D, Smith A, Pineda G, Nakano M, Michelini F, Goedegebuure S, et al.
JCO Precis Oncol
. 2023 Apr;
7:e2100489.
PMID: 37079860
No abstract available.